` Comparison: 688382 vs VRTX - Alpha Spread

I
688382
vs
VRTX

Over the past 12 months, InventisBio Co Ltd has outperformed VRTX, delivering a return of +7% compared to the VRTX's 9% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
688382
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

InventisBio Co Ltd Intrinsic Value
HIDDEN
Show
VRTX Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
I
InventisBio Co Ltd
SSE:688382
19.97 CNY
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
455.76 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
688382, VRTX

688382
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
I
InventisBio Co Ltd
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
688382, VRTX

688382
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
I
InventisBio Co Ltd
SSE:688382
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

InventisBio Co Ltd
99.9%
VRTX
86.2%

Operating Margin

InventisBio Co Ltd
-99.4%
VRTX
39%

Net Margin

InventisBio Co Ltd
-84%
VRTX
32.9%

FCF Margin

InventisBio Co Ltd
-99.1%
VRTX
26.6%

ROE

InventisBio Co Ltd
-8.2%
VRTX
22.5%

ROA

InventisBio Co Ltd
-7.7%
VRTX
16.4%

ROIC

InventisBio Co Ltd
-103.5%
VRTX
26.9%

ROCE

InventisBio Co Ltd
-9.7%
VRTX
23%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
688382, VRTX

Loading
688382
VRTX
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688382, VRTX

Performance Gap Between 688382 and VRTX
HIDDEN
Show

Performance By Year
688382, VRTX

Loading
688382
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 688382 to other stocks
PNEXF
Pharnext SCA
More expensive
vs InventisBio Co Ltd
ABBV
Abbvie Inc
Cheaper
vs InventisBio Co Ltd
AMGN
Amgen Inc
Cheaper
vs InventisBio Co Ltd
GILD
Gilead Sciences Inc
Cheaper
vs InventisBio Co Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett